Tag: Marburg

While vaccines for Ebola virus are being deployed and show high efficacy, pan-filoviral treatment is still lacking. Researchers have identified ...

A detailed study of the monoclonal antibodies from a person who survived a Marburg infection led researchers to identify novel ...

The U.S. Centers for Disease Control and Prevention has issued a funding opportunity in support of improved vector surveillance and ...

The Defense Threat Reduction Agency (DTRA) seeks to identify, adopt, and adapt emerging, existing and revolutionary sciences that may demonstrate ...

The 2018 review of the World Health Organization’s Blueprint list of priority diseases occurred February 6-7, 2018. Given their potential ...

Researchers from the University of Copenhagen and Phillips Universität Marburg have found a new target for inhibiting Ebola virus from ...

The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the advanced research and development of medical countermeasures ...

Profectus BioSciences, Inc. has received a contract for up to $22.25 million from the National Institute of Allergy and Infectious ...

A study led by scientists at the University of Texas Medical Branch Galveston National Laboratory and Mapp Biopharmaceutical has found ...

The United States continues to face national security risks from natural, accidental , and intentional health threats. Efforts to improve ...

The total number of incidents involving incomplete inactivation—a process to destroy the hazardous effects of pathogens while retaining characteristics for ...

The National Institute of Allergy and Infectious Diseases (NIAID) is seeking proposals for advanced development of multivalent vaccines against Ebola ...

Ebola virus and bats have been waging a molecular battle for survival that may have started at least 25 million ...

The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID), the Department of Defense's lead laboratory for medical biological defense ...

Military program managers briefed biopharmaceutical industry and research organization representatives during a Nov. 2 Industry Day, part of an initiative ...

The Ebola virus acts fast. The course of infection, from exposure to recovery, or death, can take as little as ...

The National Institute of Allergy and Infectious Diseases (NIAID) is seeking information from pharmaceutical and biopharmaceutical product developers on multivalent ...

The National Institute of Allergy and Infectious Diseases (NIAID) has released a new Broad Agency Announcement (BAA) to support development ...

Antibodies that identify and neutralize Marburg virus. Credit: TSRI A new study led by scientists at ...

In the past decade, the H1N1 virus and Ebola are just two of the diseases whose spread was spurred by ...